SHH MBL, for example, express a range of NKG2DL without great susceptibility to NK cell-mediated tumour clearance, as long as that HLA class I expression is high relative to often-upregulated NKG2DLs such as UL16 binding protein 2 (ULBP-2) [58]. The gene discussed is SHH; the disease is neoplasm.